Security key
40637H109
HALOZYME THERAPEUTICS, INC. - Common Stock (HALO)
CUSIP: 40637H109
Q2 2020 13F Holders as of 30 Jun 2020
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 118,494,184
- Total 13F shares
- 135,245,376
- Share change
- +5,720,337
- Total reported value
- $3,623,665,867
- Put/Call ratio
- 26%
- Price per share
- $26.81
- Number of holders
- 256
- Value change
- +$159,039,078
- Number of buys
- 157
- Number of sells
- 83
Report period
Q2 2020
Institutions
256
Top holders
10
HALO full security history
Newer quarter: Q3 2020
Previous quarter: Q1 2020
HALOZYME THERAPEUTICS, INC. SEC filings
HALOZYME THERAPEUTICS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 40637H109
Recent filing periods:
Top shareholders of HALO - HALOZYME THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Artisan Partners Limited Partnership |
13F
|
Company |
12%
|
14,430,037
|
$259,596,000 | — | 31 Mar 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
12%
|
13,898,214
|
$250,029,000 | — | 31 Mar 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
10%
|
12,146,804
|
$218,520,000 | — | 31 Mar 2020 | |
| Bellevue Group AG |
13F
|
Company |
6.5%
|
7,663,956
|
$137,874,000 | — | 31 Mar 2020 | |
| Third Security, LLC |
13F
|
Company |
5.9%
|
7,048,282
|
$126,799,000 | — | 31 Mar 2020 | |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
5.5%
|
6,563,606
|
$118,079,000 | — | 31 Mar 2020 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
4.1%
|
4,867,887
|
$87,573,000 | — | 31 Mar 2020 | |
| STATE STREET CORP |
13F
|
Company |
3.7%
|
4,364,183
|
$78,512,000 | — | 31 Mar 2020 | |
| Invesco Ltd. |
13F
|
Company |
3.1%
|
3,677,932
|
$66,166,000 | — | 31 Mar 2020 | |
| SNYDER CAPITAL MANAGEMENT L P |
13F
|
Company |
2.9%
|
3,393,057
|
$61,041,000 | — | 31 Mar 2020 | |
| EAGLE ASSET MANAGEMENT INC |
13F
|
Company |
1.8%
|
2,113,788
|
$38,027,000 | — | 31 Mar 2020 | |
| FMR LLC |
13F
|
Company |
1.7%
|
1,959,426
|
$35,250,000 | — | 31 Mar 2020 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.6%
|
1,920,758
|
$34,554,000 | — | 31 Mar 2020 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
1.6%
|
1,903,593
|
$34,245,000 | — | 31 Mar 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.6%
|
1,883,508
|
$33,883,000 | — | 31 Mar 2020 | |
| PICTET ASSET MANAGEMENT LTD |
13F
|
Company |
1.5%
|
1,784,468
|
$32,102,000 | — | 31 Mar 2020 | |
| First Light Asset Management, LLC |
13F
|
Company |
1.4%
|
1,630,591
|
$29,334,000 | — | 31 Mar 2020 | |
| First Eagle Investment Management, LLC |
13F
|
Company |
1.3%
|
1,583,675
|
$28,490,000 | — | 31 Mar 2020 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
1.3%
|
1,538,499
|
$27,678,000 | — | 31 Mar 2020 | |
| NORGES BANK |
13F
|
Company |
1.3%
|
1,528,524
|
$27,498,000 | — | 31 Mar 2020 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
1.3%
|
1,526,020
|
$27,453,000 | — | 31 Mar 2020 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
1.1%
|
1,296,003
|
$23,315,000 | — | 31 Mar 2020 | |
| Granite Investment Partners, LLC |
13F
|
Company |
1.1%
|
1,277,438
|
$22,981,000 | — | 31 Mar 2020 | |
| THRIVENT FINANCIAL FOR LUTHERANS |
13F
|
Company |
0.99%
|
1,174,208
|
$21,124,000 | — | 31 Mar 2020 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.94%
|
1,109,718
|
$19,964,000 | — | 31 Mar 2020 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.93%
|
1,104,738
|
$19,874,000 | — | 31 Mar 2020 | |
| Fisher Asset Management, LLC |
13F
|
Company |
0.92%
|
1,094,671
|
$19,693,000 | — | 31 Mar 2020 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.92%
|
1,092,902
|
$19,661,000 | — | 31 Mar 2020 | |
| CARILLON TOWER ADVISERS, INC. |
13F
|
Company |
0.89%
|
1,052,974
|
$17,184,536 | — | 31 Mar 2020 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.83%
|
989,369
|
$17,800,000 | — | 31 Mar 2020 | |
| Lombard Odier Asset Management (Switzerland) SA |
13F
|
Company |
0.76%
|
900,000
|
$16,191,000 | — | 31 Mar 2020 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.74%
|
873,192
|
$15,708,723 | — | 31 Mar 2020 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.72%
|
849,865
|
$15,289,000 | — | 31 Mar 2020 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.72%
|
848,614
|
$15,267,000 | — | 31 Mar 2020 | |
| S.c.a. Candriam |
13F
|
Individual |
0.69%
|
815,319
|
$14,131,000 | — | 31 Mar 2020 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.59%
|
700,000
|
$12,593,000 | — | 31 Mar 2020 | |
| Elk Creek Partners, LLC |
13F
|
Company |
0.55%
|
654,362
|
$11,772,000 | — | 31 Mar 2020 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.53%
|
622,891
|
$11,206,000 | — | 31 Mar 2020 | |
| PFM Health Sciences, LP |
13F
|
Company |
0.52%
|
618,726
|
$11,131,000 | — | 31 Mar 2020 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.47%
|
560,771
|
$10,088,000 | — | 31 Mar 2020 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.47%
|
553,665
|
$9,960,433 | — | 31 Mar 2020 | |
| MORGAN STANLEY |
13F
|
Company |
0.46%
|
542,736
|
$9,765,000 | — | 31 Mar 2020 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0.42%
|
499,466
|
$8,959,000 | — | 31 Mar 2020 | |
| KORNITZER CAPITAL MANAGEMENT INC /KS |
13F
|
Company |
0.4%
|
470,750
|
$8,469,000 | — | 31 Mar 2020 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.38%
|
444,702
|
$8,000,000 | — | 31 Mar 2020 | |
| CASTLEARK MANAGEMENT LLC |
13F
|
Company |
0.37%
|
437,870
|
$7,877,000 | — | 31 Mar 2020 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.36%
|
432,497
|
$7,781,000 | — | 31 Mar 2020 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.34%
|
408,757
|
$7,353,000 | — | 31 Mar 2020 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.32%
|
380,288
|
$6,841,000 | — | 31 Mar 2020 | |
| FULLER & THALER ASSET MANAGEMENT, INC. |
13F
|
Company |
0.31%
|
369,199
|
$6,642,000 | — | 31 Mar 2020 |
Institutional Holders of HALOZYME THERAPEUTICS, INC. - Common Stock (HALO) as of Q2 2020
As of 30 Jun 2020,
HALOZYME THERAPEUTICS, INC. - Common Stock (HALO) was held by
256 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
135,245,376 shares.
The largest 10 holders included
Artisan Partners Limited Partnership, BlackRock Inc., VANGUARD GROUP INC, Bellevue Group AG, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, STATE STREET CORP, JPMORGAN CHASE & CO, Invesco Ltd., Third Security, LLC, and SNYDER CAPITAL MANAGEMENT L P.
This page lists
256
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2020 vs Q1 2020 Across Filers
Q1 2020 holders
205
Q2 2020 holders
256
Holder diff
51
| Investor | Q1 2020 Shares | Q2 2020 Shares | Share Diff | Share Chg % | Q1 2020 Value $ | Q2 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.